| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 02/17/2005 | WO2005014599A1 Imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of bruton’s tyrosine kinase by such compounds |
| 02/17/2005 | WO2005014598A1 Substituted imidazopyrimidines for the prevention and treatment of cancer |
| 02/17/2005 | WO2005014597A1 N-[3-(3-SUBSTITUTED-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL)PHENYL]-SULFONAMIDES, AND COMPOSITIONS, AND METHODS RELATED THERETO |
| 02/17/2005 | WO2005014596A1 7-substituted 3-nitro-pyrazolo `1,5-a! pyrimidines |
| 02/17/2005 | WO2005014595A1 The use of fused ring-1,2,4-benzotriazine derivatives as herbicides or plant growth regulators for the control of undesired plants or vegetation, compounds and compositions thereof, and processes for their preparation |
| 02/17/2005 | WO2005013907A2 Pyrrolo[1,2-b]pyridazine derivatives |
| 02/17/2005 | WO2005013892A2 Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 02/17/2005 | WO2004106340A3 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO [3,4-d] PYRIMIDINE AND PYRROLO [2,3-d] PYRIMIDINE AND USES THEREOF |
| 02/17/2005 | WO2004106339A3 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO [3,4-d] PYRIMIDINE AND PYRROLO [2,3-d] PYRIMIDINE AND USES THEREOF |
| 02/17/2005 | US20050038261 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition |
| 02/17/2005 | US20050038247 topoisomerase inhibitors such as [5-(4-Cyclopropylcarbamoyl-imidazol-1-yl)-7-pyrimidin-2-yl-1H-benzoimidazol-2-yl]-carbamic acid ethyl ester, used for prophylaxis of bacterial infections in mammals |
| 02/17/2005 | US20050038246 PPAR active compounds |
| 02/17/2005 | US20050038099 3-Amido-5-substituted pyrazole derivatives and related compounds useful as bradykinin B1 receptor antagonists to relieve adverse symptoms in mammals mediated, at least in part, by bradykinin B1 receptor including pain, inflammation, septic shock, scarring process |
| 02/17/2005 | US20050038092 effective against aerobic and anerobic pathogens such as multi-resistant staphylococci, streptococci and enterococci, Bacteroides spp., Clostridia spp. species; side effect reductions |
| 02/17/2005 | US20050038088 N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 02/17/2005 | US20050038054 Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| 02/17/2005 | US20050038049 Prevention, therapy of disease sensitivie to kinase; Alzheimer's disease; Parkinson's disease; amyotropic lateral sclerosis; psychological disorders; schizophrenia |
| 02/17/2005 | US20050038048 Use of 7h-pyrrollo{2,3-d}pyrimidine derivatives in the treatment of solid tumor diseases |
| 02/17/2005 | US20050038043 Therapy for central nervous system disorders; anxiolytic agents; antidepressants; sleep disorders |
| 02/17/2005 | US20050038030 For thromboembolic disorder from unstable angina, acute coronary syndrome, myocardial infarction, ischemia, stroke, atherosclerosis |
| 02/17/2005 | US20050038027 Melanocortin-4 receptor agonists; obesity, type II diabetes; such as N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-(2,6,6-trimethylbicyclo(3.1.1)hept-3yl)piperazine-1-carboximidamide |
| 02/17/2005 | US20050038023 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 02/17/2005 | US20050037999 Antiproliferative agents |
| 02/17/2005 | DE10339360A1 New 7-amino-5-halo-pyrazolo-(1,5-a)-pyrimidine derivatives, useful as microbicides, especially fungicides or bactericides for protecting plants or materials such as wood |
| 02/17/2005 | CA2534528A1 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparationand use as modulators of apoptosis |
| 02/17/2005 | CA2534292A1 Substituted imidazopyrimidines for the prevention and treatment of cancer |
| 02/17/2005 | CA2532431A1 "7-substituted 3-nitro-pyrazolo [1,5-a] pyrimidines" |
| 02/17/2005 | CA2529792A1 Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 02/16/2005 | EP1506962A2 Nitrogen-containing aromatic heterocycles |
| 02/16/2005 | EP1506200A2 Novel diazabicyclic biaryl derivatives |
| 02/16/2005 | EP1506199A1 A process for the preparation of zaleplon |
| 02/16/2005 | EP1506198A1 5-ethylimidarotriazones |
| 02/16/2005 | EP1506197A1 Acyl bicyclic derivatives of pyrrol |
| 02/16/2005 | EP1506196A2 Pyrazolopyrimidines |
| 02/16/2005 | EP1506178A2 Bicyclic modulators of androgen receptor function |
| 02/16/2005 | EP1506174A2 Opioid and opioid-like compounds and uses thereof |
| 02/16/2005 | EP1505979A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles |
| 02/16/2005 | EP1397365B1 Heteroaryl-diazabicyclo-alkanes as cns-modulators |
| 02/16/2005 | EP1377584B1 Novel cyclohexenyl phenyl diazepines as vasopressin and oxytocin receptor modulators |
| 02/16/2005 | EP1251130B1 Fused purine derivatives |
| 02/16/2005 | EP1064285B1 Novel cephalotaxane derivatives and process for their preparation |
| 02/16/2005 | CN1189467C Pharmaceutically active sulfonamide derivatives |
| 02/15/2005 | US6855850 Method of manufacturing fluorine compounds, and a method of recovering or regenerating precursors of fluorinating agents |
| 02/15/2005 | US6855827 For oxidation hair dyeing |
| 02/15/2005 | US6855718 7-(r)-aminotriazolopyrimidines, the production thereof and use of the same for combatting phytopathogenic fungi |
| 02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
| 02/15/2005 | US6855708 N-arylsulfonyl aza-bicyclic derivatives as potent cell adhesion inhibitors |
| 02/15/2005 | US6855310 Aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of acetaminophen, orphenadrine or tramadol. |
| 02/15/2005 | CA2323720C New substances derived from aza-indolic polycyclics, processes for preparing them and pharmaceutical compounds containing them |
| 02/15/2005 | CA2153242C 2-alkoxy-4-hydrazinopyrimidine compounds and their use in the preparation of 5-alkoxy-1,2-4-triazolo[4,3-c]pyrimidine-3(2h)-thione compounds |
| 02/10/2005 | WO2005012524A1 Use of rnai inhibiting parp activtiy for the manufacture of a medicament for the treatment of cancer |
| 02/10/2005 | WO2005012312A1 Novel cyano thiazolides, methods for the production thereof, and use thereof as a medicament |
| 02/10/2005 | WO2005012311A1 N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 02/10/2005 | WO2005012308A1 Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments |
| 02/10/2005 | WO2005012307A1 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 02/10/2005 | WO2005012306A2 Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands |
| 02/10/2005 | WO2005012305A2 Tricyclic parp inhibitors |
| 02/10/2005 | WO2005012304A2 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 02/10/2005 | WO2005012292A1 Gyrase inhibitors and uses thereof |
| 02/10/2005 | WO2005012288A1 Bicyclic imidazol derivatives against flaviviridae |
| 02/10/2005 | WO2005012286A1 Substituted pyridones and pyrimidinones with antiinflammatory properties |
| 02/10/2005 | WO2005011675A1 Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof |
| 02/10/2005 | WO2005011609A2 Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| 02/10/2005 | WO2005011597A2 Compounds and compositions as protein kinase inhibitors |
| 02/10/2005 | WO2005011581A2 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/10/2005 | WO2004101562A3 Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors |
| 02/10/2005 | WO2004087652A3 Imidazotriazine compounds |
| 02/10/2005 | US20050034108 Processing instructions |
| 02/10/2005 | US20050033049 Heterocyclic nitrogen compounds such as 1-(5-(5-Chlorothiophen -2-yl)-isoxazol-3-ylmethyl)-1H-indole-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide, used as anticoagulants for prophylaxis of cardiovascular disorders |
| 02/10/2005 | US20050033048 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines |
| 02/10/2005 | US20050032860 CBI analogs of CC-1065 and the duocarmycins |
| 02/10/2005 | US20050032839 Useful in therapy and treatment of diseases associated with a disregulated protein kinase activity like cancer; Aurora kinases |
| 02/10/2005 | US20050032818 A regioisomer: melting point of 194-196 degrees C.; crystal structure of Forms III, IV and V as determined by x-ray diffraction peak characterization and obtained by crystallization from selected solvents; treating insomnia; substituted benzene ring repositioned at #5 rather than #7 on the fused ring |
| 02/10/2005 | US20050032804 Dihydrogenphosphate salt of 4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine; inhibitor of dipeptidyl peptidase-IV, useful for the prevention and/or treatment of non-insulin dependent diabetes mellitus |
| 02/10/2005 | US20050032803 as modulators of receptor tyrosine kinases and cytoplasmic tyrosine and serine/threonine kinases; can bind both to active and also to non-active kinases and therefore influence the signal transduction |
| 02/10/2005 | US20050032792 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
| 02/10/2005 | US20050032790 For example, 1-(2-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4,4'-bispiperidine; for treatment of thrombosis, emphysema, cirrhosis; antiarthritic agents, anticancer agents, antihistamines |
| 02/10/2005 | US20050032779 enzyme inhibitors such as 2-[4-(4-Dimethylaminophenyl)piperazin-1-yl]4,5-dihydroimidazo[4,5,1-ij]quinolin-6-one, used for treating or preventing disorders in which poly/ADP-ribose/ polymerase is involved |
| 02/10/2005 | US20050032777 benzyl carbamates and ureas such as 5-(4-(4-cyclopropylmethylpiperazine-1-carbonylaminomethyl)-3-methylbenzoyl)-1-methyl-4,10-dihydropyrazolo[5,4-b][1,5]benzodiazepine, used for treatment of sexual disorders |
| 02/10/2005 | US20050032772 Compounds useful as reversible inhibitors of cysteine proteases |
| 02/10/2005 | US20050032769 Treatment of tumors by irradiating with light after administration of protoporphyrin derivative; ethylene glycol esters of monohydrobenzoporphyrins |
| 02/10/2005 | US20050032748 Substituted 2,5-dioxopurines, 2H-1,2,3-triazolyl[4,5-d]pyrimidines, or 1,2,5-thadiazolyl[3,4-d]pyrimidines; antiproliferative, antiinflammatory, and antiarthritic agents; psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, lupus, graft versus host disease |
| 02/10/2005 | US20050032650 Fused heterocyclic sulfonylurea compound herbicide containing the same and method of controlling weed with the same |
| 02/10/2005 | US20050031899 Carbazole derivative, organic semiconductor element, light emitting element, and electronic device |
| 02/10/2005 | US20050030912 Use of hybrid (HW/DSP/MCU/SW) architectures for powerline OFDM communication field |
| 02/10/2005 | DE10331675A1 Hetarylsubstituierte Pyrazolidindion-Derivate Hetarylsubstituierte pyrazolidindione derivatives |
| 02/10/2005 | CA2537331A1 Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands |
| 02/10/2005 | CA2534649A1 Bicyclic imidazol derivatives against flaviviridae |
| 02/10/2005 | CA2534267A1 Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments |
| 02/10/2005 | CA2533893A1 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/10/2005 | CA2533774A1 Compounds and compositions as protein kinase inhibitors |
| 02/10/2005 | CA2533684A1 Substituted pyridones and pyrimidinones with antiinflammatory properties |
| 02/10/2005 | CA2533672A1 Novel cyano thiazolides, methods for the production thereof, and use thereof as a medicament |
| 02/10/2005 | CA2533423A1 Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancer |
| 02/10/2005 | CA2532382A1 N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 02/10/2005 | CA2531333A1 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 02/10/2005 | CA2531232A1 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 02/09/2005 | EP1505068A1 PYRAZOLO (1,5-a) PYRIMIDINE DERIVATIVE AND NAD(P)H OXIDASE INHIBITOR CONTAINING THE SAME |
| 02/09/2005 | EP1505067A1 4,4-disubstituted piperidine derivatives having ccr3 antagonism |
| 02/09/2005 | EP1505061A1 Compound exhibiting pgd 2 receptor antagonism |